Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 4, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-12-23
DOI
10.1038/srep07592
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Somatic Mutations and Deletions of the E-Cadherin Gene Predict Poor Survival of Patients With Gastric Cancer
- (2013) Giovanni Corso et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Survivors of Gastric Cancer: A California Population-Based Study
- (2012) Pamela L. Kunz et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial
- (2012) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of estrogen receptors in gastric cancer and their clinical significance
- (2012) Woo-Sang Ryu et al. JOURNAL OF SURGICAL ONCOLOGY
- Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung Cancer
- (2012) Jill M. Siegfried et al. Journal of Thoracic Oncology
- Estrogen receptor-α directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer
- (2011) Emi Tokuda et al. BREAST CANCER RESEARCH AND TREATMENT
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer
- (2011) Hirokuni Ikeda et al. CANCER SCIENCE
- Trends of stomach cancer mortality in Eastern Asia in 1950-2004: comparative study of Japan, Hong Kong and Singapore using age, period and cohort analysis
- (2011) Masahiro Tanaka et al. INTERNATIONAL JOURNAL OF CANCER
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2011) Atsushi Ohtsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial
- (2011) Jeeyun Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008
- (2011) Kyu-Won Jung et al. Cancer Research and Treatment
- Prognostic Role of Estrogen Receptor α and Estrogen Receptor β in Gastric Cancer
- (2010) C. Y. Xu et al. ANNALS OF SURGICAL ONCOLOGY
- Journal Club
- (2010) Breast Care
- Oestrogen receptor-α contributes to the regulation of the hedgehog signalling pathway in ERα-positive gastric cancer
- (2010) C Kameda et al. BRITISH JOURNAL OF CANCER
- Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer
- (2010) Angelo Di Leo et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- E-Cadherin Deficiency Initiates Gastric Signet-Ring Cell Carcinoma in Mice and Man
- (2009) B. Humar et al. CANCER RESEARCH
- Different Roles of Estrogen Receptors α and β in the Regulation of E-Cadherin Protein Levels in a Mouse Mammary Epithelial Cell Line
- (2008) Luisa A. Helguero et al. CANCER RESEARCH
- Endogenous estrogen exposure in relation to distribution of histological type and estrogen receptors in gastric adenocarcinoma
- (2008) Evangelos Chandanos et al. Gastric Cancer
- Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
- (2008) Salah-Eddin Al-Batran et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer
- (2008) M Barber et al. JOURNAL OF PATHOLOGY
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
- Estrogen Regulates Snail and Slug in the Down-Regulation of E-Cadherin and Induces Metastatic Potential of Ovarian Cancer Cells through Estrogen Receptor α
- (2008) Se-Hyung Park et al. MOLECULAR ENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now